Lantheus Holdings, Inc.

NasdaqGM:LNTH Stock Report

Market Cap: US$5.2b

Lantheus Holdings Valuation

Is LNTH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of LNTH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: LNTH ($81.67) is trading below our estimate of future cash flow value ($164.35)

Significantly Below Future Cash Flow Value: LNTH is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LNTH?

Key metric: As LNTH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for LNTH. This is calculated by dividing LNTH's market cap by their current earnings.
What is LNTH's PE Ratio?
PE Ratio22.7x
EarningsUS$233.56m
Market CapUS$5.24b

Price to Earnings Ratio vs Peers

How does LNTH's PE Ratio compare to its peers?

The above table shows the PE ratio for LNTH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21.8x
MMSI Merit Medical Systems
32.6x13.94%US$4.1b
HAE Haemonetics
15.7x13.74%US$2.7b
SOLV Solventum
7.5x-5.36%US$11.4b
ALGN Align Technology
31.5x15.67%US$12.9b
LNTH Lantheus Holdings
22.7x15.61%US$5.2b

Price-To-Earnings vs Peers: LNTH is expensive based on its Price-To-Earnings Ratio (22.7x) compared to the peer average (21.8x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does LNTH's PE Ratio compare vs other companies in the US Medical Equipment Industry?

4 CompaniesPrice / EarningsEstimated GrowthMarket Cap
EMBC Embecta
3.9x5.68%US$547.78m
ADVB Advanced Biomed
2.2xn/aUS$9.01m
MHUA.F Meihua International Medical Technologies
0.8xn/aUS$7.15m
ARTH.Q Arch Therapeutics
n/an/aUS$4.00
No more companies available in this PE range
LNTH 22.7xIndustry Avg. 26.6xNo. of Companies8PE020406080100+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: LNTH is good value based on its Price-To-Earnings Ratio (22.7x) compared to the US Medical Equipment industry average (26.2x).

Price to Earnings Ratio vs Fair Ratio

What is LNTH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LNTH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.7x
Fair PE Ratio23.8x

Price-To-Earnings vs Fair Ratio: LNTH is good value based on its Price-To-Earnings Ratio (22.7x) compared to the estimated Fair Price-To-Earnings Ratio (23.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LNTH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$81.67
US$92.46
+13.21%
12.23%US$114.00US$76.00n/a13
Apr ’27US$75.70
US$91.38
+20.72%
12.67%US$114.00US$76.00n/a13
Mar ’27US$74.91
US$90.69
+21.07%
15.63%US$130.00US$76.00n/a13
Feb ’27US$66.92
US$83.46
+24.72%
19.47%US$130.00US$70.00n/a13
Jan ’27US$66.55
US$83.14
+24.93%
19.68%US$130.00US$60.00n/a14
Dec ’26US$59.08
US$80.93
+36.98%
21.73%US$130.00US$60.00n/a14
Nov ’26US$57.69
US$83.07
+44.00%
21.27%US$130.00US$60.00n/a14
Oct ’26US$51.63
US$86.64
+67.81%
21.42%US$130.00US$63.00n/a14
Sep ’26US$54.90
US$88.00
+60.29%
21.88%US$130.00US$63.00n/a13
Aug ’26US$70.57
US$124.29
+76.12%
14.96%US$159.00US$81.00n/a14
Jul ’26US$79.42
US$128.31
+61.56%
11.24%US$159.00US$109.00n/a13
Jun ’26US$75.56
US$129.31
+71.13%
10.41%US$159.00US$110.00n/a13
May ’26US$105.92
US$134.92
+27.38%
10.66%US$166.00US$110.00n/a13
Apr ’26US$97.93
US$134.38
+37.23%
10.68%US$166.00US$110.00US$75.7013
Mar ’26US$93.82
US$133.92
+42.74%
10.77%US$166.00US$110.00US$74.9113
Feb ’26US$92.51
US$134.69
+45.60%
11.85%US$166.00US$110.00US$66.9213
Jan ’26US$89.46
US$134.69
+50.56%
11.85%US$166.00US$110.00US$66.5513
Dec ’25US$89.27
US$134.00
+50.11%
12.80%US$166.00US$110.00US$59.0811
Nov ’25US$107.98
US$144.55
+33.86%
9.87%US$175.00US$125.00US$57.6911
Oct ’25US$105.84
US$144.55
+36.57%
9.87%US$175.00US$125.00US$51.6311
Sep ’25US$106.47
US$141.50
+32.90%
7.79%US$165.00US$125.00US$54.9010
Aug ’25US$98.62
US$141.50
+43.48%
7.79%US$165.00US$125.00US$70.5710
Jul ’25US$80.00
US$105.50
+31.88%
8.26%US$128.00US$96.00US$79.4210
Jun ’25US$81.83
US$104.90
+28.19%
8.51%US$128.00US$96.00US$75.5610
May ’25US$67.39
US$97.50
+44.68%
12.83%US$128.00US$82.00US$105.9210
Apr ’25US$60.11
US$97.10
+61.54%
12.89%US$128.00US$82.00US$97.9310
US$92.46
Fair Value
11.7% undervalued intrinsic discount
13
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/13 11:42
End of Day Share Price 2026/04/13 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lantheus Holdings, Inc. is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Yuan ZhiB. Riley Securities, Inc.
Brian Kemp DolliverBrookline Capital Markets